biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes
← People to follow
BR
PERSON TO FOLLOW

Botond Roska

Founding Director, Institute of Molecular and Clinical Ophthalmology B

A vision researcher who worked on optogenetic sight restoration in the lab for many years before the first human results. He was described in 2021 as a co-founder of GenSight Biologics and, with José-Alain Sahel, received the António Champalimaud Vision Award in 2026.

optogeneticsretinavision restorationgene therapy

WHAT TO WATCHWork on more sensitive light sensors that his team says could improve results.

ON THE WIRE

Every story about Botond’s work.

Profile sources

  1. 1
    Optogenetic therapy shows early signs of improving vision in inherited blindness Medical Xpress
  2. 2
    Partial Vision Restored in Some Blind Patients With New Experimental Treatment ScienceAlert
  3. 3
    GenSight Biologics Announces Case Report Showing Visual Recovery after GS030 Optogenetic Treatment - Eyewire+ Eyewire+